The following guidelines sections have been re-drafted and supplied for posting; others will follow later this week. Please note that full references are not available for all drafts.
Evidence
When to start (please note that this section has been extensively revised)
What to start with
Initial failure
Adherence
Salvage therapy
Resistance
Metabolic complications of therapy: Mitochondrial toxicity
Lipodystrophy
Therapeutic drug monitoring
Process for revising the BHIVA adult antiretroviral treatment guidelines, 2001
These drafts will be revised before April 24 by the Writing Committee, after which a new draft will be made available for online discussion.
Please send any further comments to Dr Anton Pozniak.
Comments will be integrated into a second draft for discussion.